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Abstract There is growing consensus that myocardial
perfusion deficits play a pivotal role in the transition from
compensated to overt decompensated hypertrophy. The
purpose of this study was to systematically study myo-
cardial perfusion deficits in the highly relevant model of
pressure overload induced hypertrophy and heart failure by
transverse aortic constriction (TAC), which was not done
thus far. Regional left ventricular (LV) myocardial perfu-
sion (mL/min/g) was assessed in healthy mice (n = 6) and
mice with TAC (n = 14). A dual-bolus first-pass perfusion
MRI technique was employed to longitudinally quantify
myocardial perfusion values between 1 and 10 weeks after
surgery. LV function and morphology were quantified from
cinematographic MRI. Myocardial rest perfusion values in
both groups did not change significantly over time, in line
with the essentially constant global LV function and mass.
Myocardial perfusion was significantly decreased in TAC
mice (4.2 ± 0.9 mL/min/g) in comparison to controls
(7.6 ± 1.8 mL/min/g) (P = 0.001). No regional differ-
ences in perfusion were observed within the LV wall.
Importantly, increased LV volumes and mass, and
decreased ejection fraction correlated with decreased
myocardial perfusion (P \ 0.001, in all cases). Total LV
blood flow was decreased in TAC mice (0.5 ± 0.1 mL/
min, P \ 0.001) in comparison to control mice
(0.7 ± 0.2 mL/min). Myocardial perfusion in TAC mice
was significantly reduced as compared to healthy controls.
Perfusion was proportional to LV volume and mass, and
related to decreased LV ejection fraction. Furthermore, this
study demonstrates the potential of quantitative first-pass
contrast-enhanced MRI for the study of perfusion deficits
in the diseased mouse heart.
Keywords MRI  First-pass perfusion  Mouse 
Hypertrophy  Heart failure  Transverse aortic constriction
Background
Heart failure (HF) is a progressive syndrome in which the
heart is no longer capable of pumping blood at a rate
commensurate with the peripheral needs [1]. HF is an
important cause of morbidity and mortality [2–4]. In many
patients HF results from sustained, systemic hypertension
resulting in chronic left ventricular (LV) pressure overload
[5]. The heart initially adapts to this overload by means of
hypertrophic growth. However, a broad range of concom-
itant maladaptive processes, including increased collagen
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deposition, metabolic changes and microvascular remod-
eling, eventually may lead to HF [6–8].
It has long been appreciated that pressure-overload
induced LV hypertrophy is associated with alterations in the
coronary microvasculature [9–12]. The pressure-overload
hypertrophied LV is characterized by perivascular fibrosis
and arterial medial hypertrophy, while vascular densities are
lower as neovascularization does not occur commensurate
with myocardial growth [13, 14]. These abnormalities force
the myocardium to recruit its vasodilator reserve already
under resting conditions, which occurs at the expense of its
ability to increase myocardial blood flow in response to a
stressor or vasodilator [15–17]. The resultant myocardial
perfusion abnormalities during increased oxygen demands
likely have a negative impact on cardiac function. However,
the precise role of impaired perfusion in the development of
HF remains incompletely understood. For example, it is
unclear whether impaired perfusion is merely a consequence
of hypertrophy or actually drives maladaptive remodeling.
Transverse aortic constriction (TAC) in mice is a highly
relevant model of pressure overload induced hypertrophy
and plays an important role in preclinical research to
unravel the precise role of microvascular dysfunction in HF
development [17–20]. The relationship of LV hypertrophy
and decline in LV function with regional changes in
myocardial perfusion is not well established for this model.
One reason might be that quantitative myocardial perfusion
measurements in mice are experimentally very challeng-
ing. Furthermore, classical microsphere-based perfusion
quantification in the mouse heart is invasive and therefore
conducted under non-physiological conditions [21, 22].
Also, the latter technique suffers from sampling errors due
to the small mouse heart size [23].
Recently, first-pass perfusion MRI protocols have
become available enabling non-invasive quantification of
mouse heart perfusion values (in mL/min/g) in vivo [24,
25]. Makowski et al. [25] already showed a significantly
decreased perfusion in the mouse infarct area in compari-
son to other heart wall segments. More recently, we
showed that the first-pass perfusion measurements are
highly repeatable and that one can determine heart anatomy
and function during the same MRI session [26]. This offers
the unique opportunity to relate microvascular, functional
and hypertrophic adaptations in the same mouse under
identical conditions in a longitudinal fashion.
The aim of this study was therefore to apply first-pass
perfusion MRI to quantify LV regional myocardial perfu-
sion in a cohort of healthy mice and littermates that
underwent TAC resulting in LV pressure overload induced
hypertrophy. Perfusion values were related to global LV
function and morphology as obtained from cinemato-
graphic MRI. Measurements were performed 1, 2, 4, 7 and
10 weeks after TAC.
Methods
Animal model
A total of 20 C57BL/6 mice (#, age 11 weeks, 24–26 g)
were included in this study. Animals were housed under
standard laboratory conditions with a 12 h light/dark cycle
and were maintained on a standard diet with access to
water ad libitum. All animal experiments were performed
according to the Directive 2010/63/EU of the European
Parliament and approved by the local Animal Care and Use
Committee. Mice were randomly separated in a control
group (n = 6) and a group that was subjected to TAC
(n = 14), resulting in LV pressure overload (see Online
Resource 1) [20, 27].
Study protocol
All MR images were acquired as previously described using a
dedicated 9.4T small animal MRI scanner (Bruker BioSpec,
Ettlingen, Germany) (see Online Resource 1) [24, 26, 28].
MRI measurements were performed 1, 2, 4, 7 and 10 weeks
after surgery. At each session first-pass perfusion images were
acquired with a prebolus (25 lL, 40 mM Gd(DTPA)2-) and a
full-bolus (100 lL, 40 mM Gd(DTPA)2-). Perfusion quan-
tification was successful in 29/30 measurements in control
mice and 59/70 in TAC mice. Missing data points were either
due to death of mice in between measurement time points or
unsuccessful measurements, primarily due to failed contrast
agent infusion. Some datasets were excluded from further
analysis as a result of ECG distortions, but only when the
distortions led to a severely degraded image quality. In
between both boluses a 20 min waiting time ensured sufficient
clearance of Gd(DTPA)2- [26]. LV function and mass were
quantified during these 20 min (see Online Resource 1) [28].
Immediately after the last measurements the anesthetized
animals were killed by means of perfusing the vascular bed
with phosphate buffered saline (pH 7.4) infused via a needle
penetrating the apex and exsanguination from the vena cava
inferior. Next, the integrity of the TAC was visually verified
and heart wet weight, lung wet weight (LuW), and tibia length
(TL) were measured.
Data analysis
Myocardial perfusion (mL/min/g) was quantified as descri-
bed previously (also see Online Resource 1) [26]. Briefly,
signal intensity (SI) time curves from the LV blood pool and
the LV myocardium were obtained using home-built soft-
ware in Matlab (The Mathworks, Inc.). We segmented the
LV wall rather conservatively making sure that the regions
of interest did only contain pixels well within the myocardial
wall ensuring that myocardial signal was not contaminated
620 Int J Cardiovasc Imaging (2014) 30:619–628
123
by the LV lumen signal and vice versa. Regions-of-interest
were slightly adjusted per frame to correct for small position
changes of the heart due to respiration. Pre-injection base-
line signal intensity was subtracted from the signal intensity
time curve and subsequently the curves were normalized to
the pre-injection baseline signal to correct for signal recep-
tion inhomogeneities introduced by the RF receive surface
coil. For myocardial perfusion quantification, a non-satu-
rated AIF was reconstructed from four time-shifted c-variate
prebolus fits [29]. Next, perfusion was quantified using a
Fermi constrained deconvolution of the myocardial tissue
response from the full-bolus with the AIF using a Leven-
berg–Marquardt least squares fitting algorithm [30]. For
regional perfusion analysis the LV myocardium was divided
in five segments (Fig. 1). From the c-variate fittings also the
area under the curve (AUC), and the mean transit time
(MTT) defined as the full width at half maximum of the fitted
peak, were extracted. The myocardial wall was segmented
semi-automatically in the cinematographic MR images
using CAAS MRV FARM (Pie Medical Imaging, The
Netherlands) to obtain LV function and mass. Whole heart
blood flow was calculated by multiplying perfusion with LV
mass. Myocardial stroke work was estimated by multiplying
stroke volume and mean aortic pressure proximal to the
TAC, using 83 ± 5 mmHg in control and 83 ± 4 mmHg in
TAC mice based on data from van Deel et al. [20]. Finally,
the relationship between the cardiac output (CO) and the
contrast agent concentration over the first-pass ca(t), as
estimated from the AUC of the first-pass in the prebolus
injection, was assessed using the Stewart–Hamilton equa-
tion [26, 31].
CO ¼ MR
caðtÞdt ð1Þ
in which M is the injected amount of the tracer. Data
analysis required approximately one hour for each perfu-
sion measurement.
Statistics
Data are expressed as mean ± standard deviation (SD).
Differences in LV mass/TL, LV EF, stroke volume (SV),
cardiac output (CO), heart rate (HR), respiratory rate (Resp)
and bodyweight (BW) were tested for statistical significance
with an ANOVA for repeated measures with group being
control and TAC as factor, followed by the Bonferroni post
hoc test when appropriate. In case of interaction between
time and group, the effect of time was tested separately per
group. Differences in perfusion were tested for statistical
significance with an ANOVA for repeated measures with
region and group as factor, followed by the Bonferroni post
hoc test when appropriate. In TAC mice only linear regres-
sion analysis with offset was used to relate myocardial per-
fusion to LV parameters (EDV, ESV, EF, and LVmass), to
relate blood flow to CO, and to stroke work. Changes in
LuW/TL, HW/TL, blood flow, and blood flow to the heart as
percentage of CO were tested for statistical significance with
one-sided Student’s t test. Calculations were performed
using SPSS 19.0 (SPSS Inc., Chicago). For all tests the level
of significance was set at a = 0.05.
Results
All control mice completed the experimental protocol. Two
mice died during the course of the experiment at 2 and
7 weeks after TAC, respectively. General animal charac-
teristics are given in Table 1. Mouse bodyweight increased
over time (P \ 0.001), however, no significant differences
between groups were detected. Also, no differences in HR
or Resp as measured during MRI scanning were detected
between control and TAC mice.
LV functional parameters were determined from cine-
matographic MR images (see Online Resource 1). Impaired
Fig. 1 a Four-chamber long-
axis image during diastole
overlaid with endocardial and
epicardial contours and the five
segments used for regional
quantification of myocardial
perfusion. Sbase septum (basal
part), Smid septum
(midventricular part), A apex,
Lbase lateral wall (basal part),
Lmid lateral wall (midventricular
part). b Corresponding
cinematographic diastolic four-
chamber long-axis image
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systolic function in the TAC mice was apparent from an
increased EDV (P \ 0.01) and ESV (P \ 0.01), and a
decreased EF (P \ 0.001) as compared to control mice (see
Online Resource 1). In TAC mice EDV increased over time
from 78 ± 10 lL to 92 ± 19 lL (P \ 0.01), whereas ESV
(53 ± 14 lL) and EF (39 ± 8 %) remained constant over
time. No significant changes over time were detected for
EDV (70 ± 11 lL), ESV (25 ± 8 lL) and EF (65 ± 6 %)
in the control mice. Myocardial hypertrophy in TAC mice
was apparent from an increased LV mass normalized to TL
as compared to controls (P \ 0.001). In control mice LV
mass normalized to TL (5.3 ± 0.4 mg/mm) remained con-
stant over time, whereas LV mass in TAC mice gradually
increased (P \ 0.001) from 6.1 ± 0.8 mg/mm (week 1) to
7.4 ± 0.9 mg/mm (week 10). Moreover, SV was decreased
in TAC mice (33 ± 7 lL) as compared to control mice
(45 ± 7 lL) (P \ 0.001), and CO was also decreased in
TAC mice (17 ± 3 mL/min) as compared to controls
(23 ± 3 mL/min) (P \ 0.001). No significant changes over
time were detected in both groups for SV and CO.
Post-mortem whole heart weight was increased in TAC
mice as compared to controls (P \ 0.001) (Table 2). LuW/
TL ratio, which was used as a measure for pulmonary
remodeling, was only increased in three TAC mice. As a
result, the apparent increase of LuW/TL in TAC mice did
not reach significance.
Figure 2 shows a series of representative myocardial
first-pass perfusion images of a prebolus and full-bolus
experiment in a control and TAC mouse. The pictures
depict images acquired before and at different time points
after injection of a small and a relatively large quantity of
Gd(DTPA)2-, respectively. Blood and myocardial signals
were appropriately nulled before contrast agent injection.
For both bolus measurements one can observe the arrival of
Gd(DTPA)2- in the right ventricle, in the left ventricle, and
in the myocardium. For the prebolus only minor signal
enhancement was observed in the myocardium and signal
intensity in the whole image returned quickly to values
close to baseline levels, indicating strong dilution and fast
clearance of the low volume prebolus.
The mean transit time (MTT) is defined as the average
time the bolus requires for passing through a region of
interest. MTTs of the LV lumen signal from the prebolus in
the control mice (1.3 ± 0.5 s) and TAC mice (1.4 ± 0.6 s)
were not significantly different. Also, the MTT of the LV
lumen signal from the full-bolus in the control (4.8 ± 0.7 s)
and TAC mice (4.5 ± 0.6 s) were statistically the same.
Figure 3a displays two examples of arterial input functions
(AIF) for a control and a TAC mouse, which served as input
for the Fermi analysis to model the measured myocardial
tissue response and quantify the perfusion. The TAC mouse
AIF was notably higher than that of the control mouse, which
was also the case for the group averaged areas under the
curve as a measure of the AIF amplitude (61.9 ± 32.5 versus
41.2 ± 9.9 for TAC and controls, respectively). The higher
AIF was related to a decreased CO for TAC mice via the
Stewart–Hamilton relationship (Eq. 1) (Fig. 3b).
Having established that prebolus and full-bolus injec-
tions in both groups resulted in consistent signal-intensity
time curves with similar MTTs and AIFs that followed the
Stewart-Hamilton relation, myocardial tissue perfusion (in
mL/min/g) was quantified regionally for each mouse.
Figure 4 shows fits of the myocardial tissue response
curves for two representative cases of a control and a TAC
mouse.
Table 1 General animal characteristics
Week 1 Week 2 Week 4 Week 7 Week 10
BW (g) Control 25.9 ± 2.0 26.7 ± 1.6 26.8 ± 1.4 27.1 ± 1.5 29.0 ± 1.7
TAC 24.6 ± 1.6 25.6 ± 1.4 26.3 ± 1.0 26.9 ± 1.1 27.6 ± 1.2
HR (min-1) Control 515 ± 43 523 ± 29 503 ± 35 550 ± 31 524 ± 39
TAC 529 ± 40 534 ± 25 545 ± 23 539 ± 46 531 ± 28
Resp (min-1) Control 63 ± 8 48 ± 4 71 ± 16 58 ± 7 62 ± 11
TAC 58 ± 9 56 ± 9 68 ± 9 63 ± 11 69 ± 12
Mouse body weight (BW) measured before the MRI measurements, and heart rate (HR) and respiratory rate (Resp) during the MRI mea-
surements at the different time points in the study. For all parameters no significant differences between groups were detected. BW increased
over time (P \ 0.001), HR was constant over time, but Resp at week 2 was somewhat lower as compared to week 4 and 10 (P \ 0.05)
Table 2 Post-mortem assessment of hypertrophy and pulmonary
remodeling
Group Heart mass/TL (mg/mm) LuW/TL (mg/mm)
Control 9.3 ± 0.9 10.0 ± 0.9
TAC 13.2 ± 1.8 13.7 ± 7.0
Three TAC mice developed a large lung weight-to-tibia length (LuW/
TL) ratio (mg/mm) of 18.2, 23.3 and 33.5 mg/mm as compared to
10.6 ± 1.7 for the other mice in the group. This resulted in a slightly
elevated group-averaged LuW/TL ratio in the TAC mice, but the
differences did not reach significance (P = 0.11). Post mortem heart
mass normalized to TL was increased in TAC mice as compared to
controls (P \ 0.001)
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Figure 5 summarizes the group-averaged regional per-
fusion values as function of time for TAC and control
mice. Overall, no significant changes of myocardial per-
fusion with time were detected for both TAC and control
hearts. No regional differences in perfusion values within
the two groups were observed. Unexpectedly, low perfu-
sion values were found in some segments in control mice at
week 4, which we attribute to experimental difficulties at
that specific time point (see ‘‘Discussion’’). Most impor-
tantly, myocardial perfusion in TAC mice was consistently
Fig. 2 Time series of cardiac images obtained during the first-
passage of a prebolus (25 lL, 40 mM Gd(DTPA)2-) and a full-bolus
(100 lL, 40 mM Gd(DTPA)2-) in a control (two top rows) and TAC
mouse (two bottom rows). From left to right: pre-contrast, RV arrival,
LV arrival, myocardial influx, and washout. Indicated are the time
points at which each image was acquired with respect to the pre-
contrast image. Examples of cinematographic images of the prebolus
and full-bolus passage are given in Online Resource 2
Fig. 3 a Examples of an arterial input function (AIF) in a control
(left) and TAC mouse (right), which were reconstructed from the
prebolus intensity–time curves. The AUC in the AIF of the TAC
mouse was larger as compared to the one in the control mouse.
b Relationship between the cardiac output and the reciprocal of the
area under the curve (AUC) in control and TAC mice for the prebolus
injection. When assuming a linear relationship between both param-
eters, a moderate relationship was obtained (r = 0.46, P \ 0.001)
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Fig. 4 Measured myocardial
tissue responses in the five wall
segments and the corresponding
modeled signal responses,
obtained from the Fermi-
constrained deconvolution of
the myocardial tissue responses
with the AIF in control (top
row) and TAC mice (bottom
row). Sbase septum (basal part),
Smid septum (midventricular
part), A apex, Lbase lateral wall
(basal part), Lmid lateral wall
(midventricular part). These
segments are depicted in Fig. 1
Fig. 5 Myocardial perfusion in the five wall segments in control and
TAC mice as a function of time. Sbase septum (basal part), Smid septum
(midventricular part), A apex, Lbase lateral wall (basal part), Lmid
lateral wall (midventricular part). Perfusion in the TAC mice was
decreased in all segments as compared to control mice (P \ 0.05, in
all cases). In both groups no significant changes over time and
between segments were observed. Low perfusion values were found
in the lateral wall and the apex in control mice at week 4, which was
attributed to experimental difficulties (see ‘‘Discussion’’). Mean and
SD per time point are denoted by the corresponding symbol and error
bars. Statistical differences as compared to the control group are
indicated by *P \ 0.05, P \ 0.01 and P \ 0.001
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lower than in control mice. Region- and time-averaged
perfusion in TAC mice was 4.2 ± 0.9 mL/min/g, while
7.6 ± 1.8 mL/min/g for controls (P = 0.001).
In order to examine the relationship between the decreased
perfusion to the severity of hypertrophy and decline in
function in individual mice, perfusion values of the entire LV
were correlated to several functional parameters (Fig. 6).
Decreased myocardial perfusion in TAC mice was correlated
to increased LV mass (r = -0.52, P \0.001), increased
EDV (r = -0.54, P \0.001), increased ESV (r = -0.61,
P\ 0.001), and decreased EF (r = 0.51, P \0.001). Whole
heart blood flow, calculated by multiplying perfusion with LV
mass as measure for the total amount of blood supplied to the
LV, was decreased in TAC mice (0.5 ± 0.1 mL/min) as
compared to controls (0.7 ± 0.2 mL/min) (P \0.001), but
whole heart blood flow in TAC mice was not associated with
a decreased CO. The reduction in blood flow to the heart
expressed as percentage of the CO in TAC mice
(2.9 ± 0.7 %) as compared to controls (3.2 ± 0.9 %)
showed a trend towards significance (P = 0.07). Myocardial
stroke work, i.e. the work done by the LV to pump a certain
amount of blood into the aorta, was estimated by multiplying
stroke volume and mean aortic pressure, as measure for the
force delivered by the LV. Stroke work in TAC mice
(2,728 ± 540 lL mmHg) was decreased as compared to
control mice (3,681 ± 583 lL mmHg, P\ 0.001), but
myocardial stroke work in TAC mice was not correlated to
blood flow (Fig. 6).
Discussion
The TAC mouse is a well-established, valued model for
hypertrophy and HF and has been used for studying various
aspects of vascular remodeling in myocardial disease [17–
20, 28]. Despite considerable efforts the precise mecha-
nistic role of decreased myocardial perfusion in the
development of HF is not fully elucidated. In particular, the
relationship between myocardial perfusion and the evolu-
tion and severity of decline in LV function in this mouse
model has not been addressed thus far. Here, we therefore
investigated the effect of LV pressure overload induced
hypertrophy on myocardial perfusion in the TAC mouse
model using quantitative first-pass perfusion MRI, and
Fig. 6 Relationship between average perfusion (mL/min/g) in indi-
vidual hearts and the left ventricular end-diastolic volume (EDV) (top
left), end-systolic volume (ESV) (top middle), ejection fraction (EF)
(top right) and LV mass (bottom left), and between the whole heart
blood flow and the cardiac output (bottom middle), and the stroke
work (bottom right). Whole heart perfusion was calculated by
multiplying left ventricular perfusion with LV mass. Stroke work was
calculated by multiplying stroke volume with the estimated mean
aortic pressure. The mean and SD for the control mice are denoted by
the corresponding symbol and error bars. For TAC mice all
measurement points are shown and the results (Pearson correlation
coefficient and significance) of the linear regression analysis are
shown in each panel
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related the perfusion data to the severity and time-course of
global left ventricular dysfunction.
Hypertrophy in the TAC mice was apparent from a
significantly increased LV mass, while considerably
increased EDV and ESV denoted LV dilation. Moreover,
LV function was compromised, indicated by decreased EF,
SV, and CO. Profound pulmonary remodeling, as assessed
from the LuW/TL ratio, was only observed in three out of
fourteen TAC mice. Taken together, from the anatomical
data and MRI measurements it can be concluded that the
TAC surgery resulted in a state of stable cardiac dysfunc-
tion rather than progressive HF.
Myocardial perfusion was studied under resting condi-
tions, i.e. the vasculature was not maximally vasodilated.
Under these conditions, perfusion values in TAC mice
were almost twofold lower than those for control mice.
Group-averaged perfusion values in both groups were
found to be constant over time. The apparent decrease of
myocardial perfusion observed at week 4 in the apex and
both lateral segments of the control mice was likely due to
problems with the cardiac triggering. These occurred in 4
out of the 6 measurements and resulted in severe distor-
tions of the first-pass images. LV mass and EDV in TAC
mice progressively increased over time and therefore per-
fusion values were correlated in more detail to LV function
and morphology (Fig. 6).
Decreased myocardial perfusion in TAC mice was
clearly correlated to increased EDV and ESV, decreased
EF and increased myocardial mass (Fig. 6). Interestingly,
even for the TAC mice without a substantial increase in LV
mass, rest perfusion was lower as compared to control mice
with the same LV mass (arrow in Fig. 6). Such reduced
resting-state perfusion in the absence of LV hypertrophy
was also observed in patients with arterial hypertension
[32]. We propose that this is the result of a hemodynamic
effect caused by the induction of LV pressure overload.
The further decrease of perfusion with increased myocar-
dial mass can be attributed to a decreased capillary density,
as hypertrophic myocardial growth outweighs neovascu-
larization [33].
Pathological myocardial hypertrophy is associated with
an increased cardiac workload causing an increased O2
demand, which should be met by increased myocardial
perfusion. Instead, myocardial perfusion and perfusion
reserve are impaired in pathological cardiac hypertrophy
[10]. The resulting lower O2 delivery capacity has direct
functional consequence in terms of impaired myocardial
contractility and may even promote apoptosis and fibrosis
[7, 34]. In our data we indeed observed a significant
impairment of EF simultaneous with an impaired myo-
cardial perfusion and, importantly, a further decrease of
perfusion was strongly associated with a further reduction
of the EF (Fig. 6).
Myocardial stroke work was estimated by multiplying
stroke volume and mean aortic pressure. Invasive pressure
measurements, for example with a conductance catheter,
could not be combined in the same mice with longitudinal
MRI measurements. Therefore, mean aortic pressure in
control and TAC mice had to be deduced from earlier
observations in slightly older mice and anesthetized using
2.5 % isoflurane in O2/N2 (50/50 vol%) [20]. The dimin-
ished blood flow to TAC hearts resulted in a decreased
stroke work.
In larger mammals perfusion deficits in hypertrophic
hearts are often better reflected by impaired perfusion
reserve than by resting state perfusion values [10, 35].
Here, a part of the perfusion reserve is employed to
maintain a near normal or even slightly increased baseline
perfusion. In contrast, basal metabolism in healthy mice is
relatively high resulting in a concurrent high baseline
perfusion in mice (6–8 mL/min/g) as compared to larger
mammals (0.5–1.5 mL/min/g). This may limit recruitment
of perfusion reserve to fully compensate for impaired
perfusion in face of LV pressure overload, resulting in
detection of perfusion abnormalities under resting condi-
tions in mice. Moreover, even though perfusion values
were in agreement with mouse resting state perfusion
values previously reported, we cannot exclude that the use
of isoflurane as anesthetic might have resulted in some
vasodilation and thus in increased resting state myocardial
perfusion [36], potentially enhancing perfusion differences
between TAC and control mice [37].
Oxygen consumption and therefore myocardial perfu-
sion are closely related to heart rate [38]. For that reason,
mouse body temperature and heart rate were carefully kept
constant during MRI measurements and between groups.
As a result, no relation between heart rate and myocardial
perfusion was observed.
Myocardial perfusion measurements were performed in
a long-axis orientation to assess possible perfusion differ-
ences between basal, midventricular and apical regions [32,
39]. However, such differences were not observed in our
data. It remains to be determined whether such differences
are manifested when the compensated stage of hypertrophy
in the present study progresses to overt HF. The long axis
measurements might have resulted in some partial volume
effects in slice direction in the presence of the curved
myocardial wall, particularly near the apex. However, we
found no evidence that partial volume effects interfered
with the analysis of regional differences in perfusion values
(Fig. 5).
Patients with an aortic valve stenosis often suffer from
myocardial ischemia, but the causative mechanisms are
poorly understood. Similarly, the relieve of this ischemic
condition upon replacement of the aortic valve is also not
well understood [40]. First-pass perfusion measurements in
626 Int J Cardiovasc Imaging (2014) 30:619–628
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TAC mice before and after removal of the constriction
might help to gain new insights in this phenomenon [41].
Quantification of transmural perfusion, especially when
combined with ventricular pressure measurements, could
be of particular interest to assess the potential contribution
of impaired endocardial perfusion on this ischemic
condition.
There are some limitations to this study. First, in future
work our method could be extended to measure the per-
fusion reserve, for example using adenosine or even a
higher dose of isoflurane to produce maximum coronary
artery vasodilation [10, 42]. This will provide valuable
additional information on maximal myocardial perfusion
capacity. Hartley et al. [17] studied coronary blood flow
velocity using Doppler ultrasound. Coronary flow reserve
gradually diminished over time until it was virtually
absent, 3 weeks after TAC, mainly as a result of increased
baseline coronary flow velocity, also suggesting an
impaired myocardial perfusion reserve. In particular, such
measurements might be of great value when related to
other parameters obtained from a multiparametric MRI
protocol. One example is fibrosis, which is known to have
detrimental effects on myocardial perfusion [13]. As
measurement of the perfusion reserve with the present
method requires two dual-bolus injections, the effects of
Gd(DTPA)2- accumulation and prolonged anesthesia
duration on the repeatability of the perfusion quantification
method needs careful consideration. Second, young adult
mice were used. Young animals possess the ability to
maintain relatively normal capillary density in response to
a pressure overload, a capacity that decreases with age
[14]. Thus, the use of animals at an early age might lower
the relevance for perfusion deficits in HF. Nevertheless, the
TAC mice in our study did develop perfusion deficits in
response to LV pressure overload.
Conclusions
Pressure overload induced cardiac hypertrophy in TAC
mice significantly reduced myocardial perfusion as com-
pared to their healthy littermates. Moreover, the perfusion
deficit in the hypertrophic mouse heart was proportional to
LV volume and mass, and was related to decreased LV
ejection fraction. The results from this work show the
potential of quantitative first-pass perfusion MRI for the
study of the perfusion status of the diseased mouse heart.
This technique could also provide valuable information for
the quantification of pro-angiogenic therapies for the
treatment of ischemic heart disease and to monitor the
effects of stem cell therapy, in particular when the perfu-
sion tool is incorporated in a multi-parametric MRI
protocol.
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